Project Grant K23DK146149
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Massachusetts General Hospital a $199,130 Project Grant on July 15, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award funds research on Patient-Reported Outcome Measure (PROM) utilization to advance patient-centered chronic kidney disease (CKD) care through March 31, 2030. The project will develop and validate risk...
- Federal Grant Award Summary The University of California, San Francisco received a $810,330 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded September 4, 2025, with completion targeted for June 30, 2030. This research initiative addresses significant racial and ethnic disparities in access to kidney replacement therapy (KRT) modalities, including...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases awarded a $661,694 project grant to Massachusetts General Hospital (The General Hospital Corporation), effective September 3, 2025, through June 30, 2029, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This award funds research to understand the role of FANCD2, a protein previously studied primarily in DNA repair and cancer contexts, in kidney...
- Federal Grant Award Summary Boston University Medical Campus received a $478,011 project grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded September 11, 2025, with completion targeted for August 31, 2027. The grant funds development of an automated deep learning platform designed to analyze transmission electron microscopy (TEM) images of kidney tissue....
- Federal Grant Award Summary Beth Israel Deaconess Medical Center, Inc. (BIDMC) received a $659,358 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 4, 2025, with completion targeted for June 30, 2030. The grant supports biomedical research aimed at understanding the mechanisms of APOL1 nephropathy, a kidney disease...
- Federal Grant Award Summary New York University School of Medicine received a $842,633 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 24, 2025, with a completion date of July 31, 2030. This research initiative will develop an optimal prehabilitation program specifically designed for kidney transplant (KT) candidates undergoing...
- Federal Project Grant Award Summary Harvard Medical School received a $464,750 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 11, 2025 through August 31, 2027. The award funds development of an advanced renal diagnostic platform integrating multiplexed immunofluorescence imaging capable of analyzing up to 20 antibodies...
- Federal Project Grant Award Summary Brigham and Women's Hospital Inc. received a $2.47 million Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) effective September 1, 2025, through August 31, 2029. The award funds research focused on developing a kidney-draining lymph node-targeted nanotherapeutic to treat crescentic glomerulonephritis (CGN), a severe...
- Federal Grant Award Summary Boston Children's Hospital received a $801,000 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 15, 2025, with completion targeted for July 31, 2030. The award supports basic biomedical research investigating the role of stress granules (SGs) in red blood cell development and erythropoiesis. The research...
- Federal Grant Award Summary Beth Israel Deaconess Medical Center, Inc. (BIDMC) received a $737,034 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 1, 2025, with completion targeted for June 30, 2030. The grant funds basic biomedical research aimed at understanding the regulation and biosynthesis of coenzyme A (CoA), a critical...
Boston Medical Center Corporation has been awarded $194,147 under a Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) for the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective February 1, 2026, through November 30, 2030. The grant supports the development and testing of a first-person storytelling (FPS) narrative video education intervention tailored specifically for Spanish-speaking populations with advanced kidney disease. This initiative addresses a critical gap in culturally and linguistically concordant pre-dialysis education, which has been shown to reduce urgent and suboptimal dialysis initiation rates and improve health outcomes in this underserved population. The project deliverables include the development and conduct of a best-worst scaling survey instrument to quantify patient preferences regarding intervention delivery, followed by the tailored development of narrative video materials through iterative educational material development. By centering patient lived experiences and leveraging evidence-based digital narratives, the intervention aims to improve kidney replacement therapy (KRT) education and outcomes for Spanish-speaking individuals with limited English proficiency who experience disproportionately higher rates of kidney disease. The research aligns with NIDDK's mission to disseminate and implement evidence-based strategies to improve health outcomes and engage stakeholders as research partners.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $194.1k | 1/26/26 |